Therakos, Inc. Company Profile
Therakos, Inc., a Johnson & Johnson company, has been a pioneer for more than 20 years in immune cell therapies. Therakos, Inc. markets the only approved integrated systems for extracorporeal photopheresis. For more information, visit www.therakos.com.
News Articles
TEXT-S&P assigns Therakos 'B' corporate credit rating
Overview -- U.S.-based health care company Therakos Inc. is issuing $290 million of debt to partly fund its leveraged buyout (LBO) by the Gores Group. -- We are assigning Therakos our 'B' c...
Gores Group buys [Therakos] from [J&J]'s [Ortho-Clinical Diagnostics]
[Johnson & Johnson]’s [Ortho-Clinical Diagnostics Inc.] is selling [Therakos Inc.] (light-activated cancer drug treatment) to PE firm Gores Group. Twenty-five-year-old Therakos offers the only regu...
The Gores Group Completes the Acquisition of Therakos, Inc. from Ortho-Clinical Diagnostics, Inc.
The Gores Group, a global investment firm focused on acquiring controlling interests in mature and growing businesses, today announced that it has completed the acquisition of The...
The Gores Group, a global investment firm focused on acquiring controlling interests in mature and growing businesses, today announced that it has made a binding offer to acquire...
Gores closes buyout of blood cancer device firm
The Gores Group has finalized its buyout of Therakos, a maker of systems for treating blood cancer as well as devices for pat -More-
Gores Group to acquire blood-treatment device maker Therakos
The Gores Group said it has entered a deal to acquire Johnson & Johnson unit Therakos, a maker of a device to treat a form of -More-
PubMed Articles
None
Clinical Trials
Extracorporeal Photopheresis Pilot Study
ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...
The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex
To determine the safety and patient tolerance of UVAR Photopheresis System (extracorporeal photopheresis) in the Treatment of AIDS-Related Complex (ARC).
Companies
Therakos, Inc., a Johnson & Johnson company, has been a pioneer for more than 20 years in immune cell therapies. Therakos, Inc. markets the only approved integrated systems for extracorporeal photophe...
More Information about "Therakos, Inc." on BioPortfolio
We have published hundreds of Therakos, Inc. news stories on BioPortfolio along with dozens of Therakos, Inc. Clinical Trials and PubMed Articles about Therakos, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Therakos, Inc. Companies in our database. You can also find out about relevant Therakos, Inc. Drugs and Medications on this site too.
